By bertrand
June 16 2026 Cardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment Cardiawave_PR_First_treatments_aortic_Stenosis_15 06 2026Download << Press Release
By bertrand
🎤Join us on a live webinar on June 10, 2026! June, 02 2026 Join us on June, 10 for a live webinar dedicated to the future of non-invasive cardiac care Following the CE marking of Valvosoft®, Cardiawave is entering a new phase of development across Europe, UK, Middle East and Africa. During this session, we … Continued
By bertrand
04/12/2025 VALVOSOFT®, the first non-invasive treatment for severe Symptomatic Aortic Stenosis (sSAS) from Cardiawave receives CE Marking Cardiawave_PR CE Mark Valvosoft 2025-12-04Download << Press Release
By bertrand
04/12/2025 VALVOSOFT®, le premier traitement non invasif de la Sténose Aortique Sévère symptomatique (sSAS) développé par Cardiawave, obtient le marquage CE Cardiawave_PR CE Mark Valvosoft 2025-12-04_FRDownload << Press Release
By bertrand
27/10/2025 Cardiawave renforce son leadership avec la nomination de Jonathan Freeman, Président du CA PR Cardiawave Nomme Jonathan Freeman Président du CA – 27 10 2025Download << Press Release
By bertrand
23/10/2025 Cardiawave Strengthens Leadership with Appointment of Jonathan Freeman as Board Chairman PR Cardiawave Appoints Jonathan Freeman as COB – 23 10 2025Download << Press Release
By bertrand
Cardiawave featured by LSI Europe ‘25 as one of the selected innovators presenting in London this September! August 12th 2025 🚀 We are proud to be featured by LSI Europe ‘25 as one of the selected innovators presenting in London this September! Our CEO Carine Schorochoff will showcase non-invasive ultrasound therapy (NIUT) for the treatment of Aortic Stenosis at various stages of the disease. Using non-thermal … Continued
By bertrand
Cardiawave CEO Carine Schorochoff on France Biotech’s 100% HealthTech! August 7th 2025 🫀 Can we treat certain heart conditions without opening the chest? At Cardiawave, we believe the answer is yes. During the 100% HealthTech live broadcast hosted by France Biotech, our CEO Carine Schorochoff was invited to speak on the program Parole d’entrepreneur, moderated by Fabrice Lundy. Carine presented Cardiawave’s mission and … Continued
By bertrand
New article in Cath’Lab ! July 29th 2025 📰 We are pleased to share an article published in Cath’Lab that highlights the potential of non-invasive ultrasound therapy (NIUT) as an alternative approach for patients with symptomatic severe aortic stenosis (sSAS)who are not eligible for valve replacement procedures. The article presents the principles behind this technology developed by Cardiawave, and its … Continued
By bertrand
Cardiawave on Sud Radio July 22nd 2025 📻 Cardiawave was recently featured on Sud Radio, a national French radio station. In this interview, Professor Emmanuel Messas and Dr. Matthieu Pernot, two of the co-founders of Cardiawave, present our non-invasive ultrasound therapy for the treatment of aortic stenosis. They explain the technology, its clinical applications, and the development path of the company. Thanks … Continued